Jonathan Leff is an Executive Partner at Sofinnova Investments with over 25 years in biotech and pharma drug development. He focuses on strategic drug development and serves on boards of Axonis, Expedition, and NorthSea.








At firms with a similar stage, sector and check size.





One email when Jonathan's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJonathan Leff is an Executive Partner at Sofinnova Investments with over 25 years in biotech and pharma drug development. He focuses on strategic drug development and serves on boards of Axonis, Expedition, and NorthSea.
Jonathan Leff invests through Sofinnova Investments, which writes checks of $10M to $30M at series a, series b.
Email [email protected], the firm's inbox for founders, and name Jonathan in the subject. A warm intro from a founder Sofinnova Investments backed works better.
Vice President and Chief Medical Officer at Halozyme Therapeutics; Chief Medical Officer at KaloBios Pharmaceuticals; Executive Vice President, Research and Development at InterMune; Senior Vice President and Chief Medical Officer at Ascendis Pharma; Merck; Amgen; Roche.
Last updated 2026-10-15. Is this you? Ask for a correction.